Demographic and baseline characteristics
| Characteristic . | n . | % . |
|---|---|---|
| Sex | ||
| Male | 20 | 91 |
| Female | 2 | 9 |
| Race | ||
| White | 15 | 68 |
| African American | 6 | 27 |
| Other | 1 | 5 |
| Ethnicity | ||
| Hispanic | 5 | 23 |
| Non-Hispanic | 17 | 77 |
| Age, y | ||
| Median | 48 | |
| Range | 34-66 | |
| CDC risk group | ||
| Homosexual/bisexual contact | 15 | 68 |
| Heterosexual contact | 5 | 23 |
| Homosexual and heterosexual contact | 1 | 5 |
| IV drug use | 1 | 5 |
| Receiving ART at enrollment | 20 | 87 |
| Absolute CD4 count, μL | ||
| Median | 315 | |
| Minimum-maximum | 45-773 | |
| HIV viral load, copies/mL | ||
| Median | Undetectable | |
| Minimum-maximum | Undetectable to 241 490 | |
| Ann Arbor stage | ||
| I | 3 | 14 |
| II | 3 | 14 |
| IIE | 1 | 5 |
| III | 3 | 14 |
| IV | 12 | 55 |
| Lymphoma diagnosis | ||
| DLBCL | 15 | 68 |
| PEL | 2 | 9 |
| Plasmablastic lymphoma | 3 | 14 |
| Hodgkin lymphoma | 2 | 9 |
| Characteristic . | n . | % . |
|---|---|---|
| Sex | ||
| Male | 20 | 91 |
| Female | 2 | 9 |
| Race | ||
| White | 15 | 68 |
| African American | 6 | 27 |
| Other | 1 | 5 |
| Ethnicity | ||
| Hispanic | 5 | 23 |
| Non-Hispanic | 17 | 77 |
| Age, y | ||
| Median | 48 | |
| Range | 34-66 | |
| CDC risk group | ||
| Homosexual/bisexual contact | 15 | 68 |
| Heterosexual contact | 5 | 23 |
| Homosexual and heterosexual contact | 1 | 5 |
| IV drug use | 1 | 5 |
| Receiving ART at enrollment | 20 | 87 |
| Absolute CD4 count, μL | ||
| Median | 315 | |
| Minimum-maximum | 45-773 | |
| HIV viral load, copies/mL | ||
| Median | Undetectable | |
| Minimum-maximum | Undetectable to 241 490 | |
| Ann Arbor stage | ||
| I | 3 | 14 |
| II | 3 | 14 |
| IIE | 1 | 5 |
| III | 3 | 14 |
| IV | 12 | 55 |
| Lymphoma diagnosis | ||
| DLBCL | 15 | 68 |
| PEL | 2 | 9 |
| Plasmablastic lymphoma | 3 | 14 |
| Hodgkin lymphoma | 2 | 9 |
CDC, Centers for Disease Control and Prevention.